Table 1. Clinical characteristics of patients with ischemic cardiomyopathy.
| RNAseq analysis | Protein analysis | |
|---|---|---|
| ICM (n = 13) | ICM (n = 20) | |
| Age (years) | 54 ± 7 | 55 ± 8 |
| Gender male (%) | 100 | 100 |
| NYHA class | 3.5 ± 0.4 | 3.6 ± 0.4 |
| Prior smoking (%) | 84 | 86 |
| BMI (kg/m2) | 26 ± 4 | 26 ± 4 |
| Total cholesterol (mg/dL) | 162 ± 41 | 170 ± 39 |
| Hypercholesterolemia (%) | 17 | 15 |
| Prior hypertension (%) | 30 | 33 |
| Prior diabetes mellitus (%) | 38 | 42 |
| Hemoglobin (mg/mL) | 14 ± 3 | 14 ± 2 |
| Hematocrit (%) | 41 ± 6 | 41 ± 5 |
| Duration of disease (months) | 45 ± 40 | 40 ± 37 |
| Echo-Doppler study | ||
| EF (%) | 24 ± 4 | 24 ± 5 |
| FS (%) | 13 ± 2 | 14 ± 4 |
| LVESD (mm) | 55 ± 7 | 55 ± 9 |
| LVEDD (mm) | 64 ± 7 | 63 ± 9 |
Data are showed as the mean value ± SD. ICM, ischemic cardiomyopathy; NYHA, New York Heart Association; BMI, body mass index; EF, ejection fraction; FS, fractional shortening; LVESD, left ventricular end-systolic diameter; LVEDD, left ventricular end-diastolic diameter.